Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases. The treatment is based on the surgery which must be as wide as possible. The efficacy of adjuvant therapy in the control of SEF is not yet demonstrated. Chemotherapy is used in recurrences, some have also proposed radiotherapy. Long-term follow-up of patients with SEF is therefore essential.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422754 | PMC |
| http://dx.doi.org/10.11604/pamj.2020.36.131.18668 | DOI Listing |
Publication Analysis
Top Keywords
sclerosing epithelioid
8
epithelioid fibrosarcoma
8
fibrosarcoma rare
4
rare serious
4
serious sclerosing
4
fibrosarcoma sef
4
sef rare
4
rare form
4
form soft
4
soft tissue
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!